Potential of Molecular Imaging to Advance Molecular Medicine
Journal Title: Cancer Studies & Molecular Medicine – Open Journal - Year 2017, Vol 3, Issue 1
Abstract
Molecular imaging is a technology that allows for non-invasive interrogation of physiological and biochemical processes in the body. Over the years, the use of Molecular Imaging is on the rise, especially towards diagnosing cancer and monitoring treatment. Molecular Imaging has a significant role to play at preclinical and translational stages in the field of Molecular Medicine. Molecular Imaging tools include Magnetic Resonance Imaging (MRI), Magnetic Resonance spectroscopy (MRS), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound (US), and Optical Imaging among many more. While CT and MRI remains as first-line tools for diagnosing ailments by the clinicians, pre-clinical and clinical use of Positron Emission Tomography (PET) is steadily rising. Newer PET probes are being developed and being evaluated for their effectiveness in patient care and disease management. While this technology has tremendously benefitted the pre-clinical research, it has also become one of the indispensable tools in the clinic. In addition, now PET is proven to be quite helpful in expediting the drug development and discovery efforts. Over the last two decade, a significant progress is made towards expanding the role of Molecular Imaging. It plays significant role in Oncology, Neurology, ageing, drug abuse, and cardiac applications. With increased acceptance of this modality in the clinics around the world, there is a growing interest in utilizing PET to target biological systems and to assess the outcome of certain treatments in patients.
Authors and Affiliations
Pradeep K. Garg
Keywords
Related Articles
- EP ID EP551984
- DOI 10.17140/CSMMOJ-3-e004
- Views 111
- Downloads 0
Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma using RNA-Seq Data
Background: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are two primary subtypes of non-small cell lung carcinoma (NSCLC). Currently, the most widely used method to discriminate between LUAD and LU...
Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy
Triple Negative Breast Cancer (TNBC) is characterized as a lack of expression of the hormonal receptors, estrogen and progesterone, and Human epidermal growth factor receptor 2 (HER2) and as such is unresponsive to curre...
The Emerging Role of p27 in Development of Diseases
The cell cycle regulation and tumor suppressor p27 encoded by CDKN1B plays a key role in many cellular events.1-3 p27 is a member of the Cip/Kip family of cyclin-dependent kinase (CDK) inhibitors, which functions to nega...
Application of Radionuclides and Antibody-Drug Conjugates to Target Cancer
Radionuclide therapy and antibody-drug conjugates are used to locate and kill cancer cells by the utilisation of monoclonal antibodies. These bio-vectors are able to transport a cytotoxic drug payload and/or radiation in...
The Proportion of ALDEFLUOR-Positive Cancer Stem Cells Changes with Cell Culture Density Due to the Expression of Different ALDH Isoforms
A significant number of discrepancies exist within the literature regarding ALDEFLUOR-positive stem cell populations in cell lines. We hypothesized that these inconsistencies resulted from differences in culture conditio...